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a 3 cm graft was removed and cleared from the boundaw tissue, so that 
it became sulfidentty thin. A Palmaz or a Palmaz-Schatz slant was then 
covered by the vein graft. Thirteen AVGCSs were implanted percutaneously 
through a 10F guiding catheter in 13 pts suffering from angina (12 male, 1 
female, mean age 58 4- g years). Two AVGCSs were tcwplanted in by-pass 
vein grafts, 2 in the left anterior descending artery, 8 tn the right coronary 
adery, and one in the left elmumflex. Quantitative coronary angiography was 
performed to measure the minimal uminal diameter (MLD). The pts were 
discharged from the hospital under anticoagulaticn treatment. Results: De- 
ployment of the AVGCS was successful in all caseS, The mean MLD was 
incraesad from 0.41 :E 0.t to 3.2f ± 0.2 mm (p < 0.001). No complications 
were encountered uring the procedure. The TST was negative in all 4 pts, 
that underwent he examination. All I~tS were free of angina at a follow-up 
period of 4.2 :E 1.5 monthS. Conclusion: Implantation of AVGCS in humans 
is a feasible procedure with excellent immediate results. Further studies 
am warranted, however, to investigate the efficacy of AVGCS, in terms of 
reducing the incidence of acute thrombosis and late mstenosia. 
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~ Prognostic Value of  History of  Congestive Heart a 
Failure in Patients Undergoing Pereutaneous 
Coronary Interventions 
R. David Anderson, Nancy M. Wildermann, David R. Holmes Jr., 
Christopher M, O'Conner, Robert A. Harrington, Hany R, PhillipS, Robert 
M. Califf, E. Magnus Ohman. Duke University, Durham, NC 
To evaluate the clinical and engiogrephiC outcomes in pts with LV dysfunction 
undergoing PTCA/DCA with and without symptoms of CHF we examined 
2017 pts. Pts were pooled from 4 muiticenter tdals with 6 to 9 me follow-up 
and grouped according to EF: < 30%, 30-40%, and > 40%. Pts with reduced 
EF were morn frequently male (89°/= vs 77% vs 73%), had more CHF (48% 
vs 17% vs 9%), previous CABG (48% vs 27% vs 15%), MI (79% vs 83% vs 
51%) and 3-vessel disease (13% vs 11% vs 6%). Pts with EF < 30% had 
lower procedural success (QCA stenosia _< 50%) rates (61% vs 81% vs 81%) 
but similar restenosfs rates HIP/o vs 47% vs 47%). Mortality and composite 
outcome (death, MI, CABG and repeat PTCA) were: 
EF < 30% EF 30-40% EF > 40% 
-CHF 'H3HF -CHF +CHF -CHF +CHF 
n -24  n=S2 n=153 n=31 n= 1671 n=gg 
Death (30 d) 8% 14% 1% 3% 1% 2% 
Death (e me) 17% 32% 3°4, 6% 1% 4% 
Comp (9 me) 46% 64% 34% 39% 37% 28% 
Muitivariable logistic regression showed no association between EF/CHF 
and 9 me rates of MI, CABG or PTCA. A significant association between 
mortality and EF (x 2 = 23, p = 0.0001) and history of CHF (x 2 = 24, p = 
0.006) was obsewed. A clinical history of CHF added to EF (p = 0.02) in 
predicting 9 me mortality. In conclusion, CHF history and EF am important 
clinical variables that portend poor eady and late outcomes in pts undergoing 
percuteneous interventions. 
4:15 
~ Intravaecular Ultrasound Evidence for  Balloon 
Oversizlng in Diabetics: A Factor in Higher 
Complication Rates? 
Anthony C. De France, E. Murat Tuzcu, Kheled M. Zinda, William 
A, Magyar, Nirav Shah, David J. Molitemo, Patrick L. Whitlow, Irving France, 
Stephen G. Ellis, Steven E. Nissen. Cleveland Clinic, OH 
Objectives: Diabetic paflents have higher beiton angioplasCy complication 
rates and increased risk of mstenosis. We sought to determine whether 
dilfersnces in vessel size or morphology by intravasculer ultrasound could 
explain this phenomenon. 
Methods: We evaluated 313 interventions in244 patients who underwent 
primary or adjunctive balloon angiopiasty. Angiographie and ultrasound lumi- 
nal diameters, media-edvenUUa diameter and area, and degrees of arc with 
calcification were measured at "normal" reference sites adjacent to target 
lesions. Measurements were pedorrned in a laboratory blinded to clinical 
variables. Patients with a history' of diabetes were compared to patients 
without known diabetes 
Recurs: Relerence Sttes Diabetes No Diabetes jo 
n = 46 n = 267 value 
Angto Lumen Diameter (ram) 3.36 3,35 NS 
Ultrasour~ Lumen Diameter tram) 3,15 3.21 NS 
Maximum Balloon Size (ram) 3A3 3.47 NS 
Extent of Cs~t ion  (degrees) 33.6 19.t 0.0005 
Media-Adventltls Area (ram 2) 12.77 14.07 0.02 
Salloon/Aegio Diameter Ralio 1,02 1.04 NS 
Bagoon/IVUS Media Ratio 0.86 0.82 0.03 
Conc/asior~: Thus, diabetic and non-diabetic patients have compara~e 
engiagraphtc and ultrasound mr..fence vessel diameters, are dilated with 
similar balloon sizes, and have cempamble ratios of balloon size to anglo- 
graphic reference diameter, Hnwever, diabetics have much higher likelihood 
of ultrasound-detected calcification and have a significantly smaller media- 
adventttia area by ultrasound, This phenomenon results in a significantly 
higher balloon to media ratio which may explain the higher complication 
rates in clinical studies, 
4 :30 
~ Immediate and Long-Term Clinical Outcome in 
Patients Undergoing Angioplasty of Occluded Vein 
Grafts 
Peter B. Berger, Malcolm R. Bell, Robert Simari, Guy S. Reeder, Diane 
E. Grill, David R. Holmes Jr.. Mayo C/In/c, Rochester, MN 
To determine the immediate and long-term clinical outcome associated with 
PTCA of occluded vein grafts, we analyzed 77 consecutive patients (LotS) 
without an MI 3 24 hours in whom PTCA of an occluded vein graft was 
attempted. New devices (slants, atherectomy, or laser) were used in 48=/° of 
procedures; intravascuiar thmmbolytic therapy was used in 23%. Myocardial 
infarcticn (MI) had occurred 1 to 7 days pdor to PTCA in 22 pts (29%). Mean 
age was 65 yrs: 8"P/O were male. Class 3 or 4 angina was present in 85=/o; 
79% had a prior MI, 26% had a hx of CHR Mean graft age was 7.5 =k 3.9 
yrs. Angiographic success (< 50% residual stenosis) was achieved in 71% 
of procedures (in 68=/= of pts with a recent MI vs 73% in the remaining lOtS). 
The 30 day mortality was 5.2%; 1% of pts suffered a Q wave MI and 8% 
underwent repeat CABG within 30 days. Univariate analysis indicated that 
the graft age, but not angiographio failure, was associated with death and MI 
throughout he hospitalization and foflow-up period. During follow-up (mean 
2.0 ~: 1.9 yrs), them was no difference in 3 yr survival between pts in whom 
angiographtc success had and had not been achieved (68% vs 76%), nor 
was them a difference in freedom from either MI (75% vs 74%), repeat PTCA 
or CABG (49% vs 48%) orthe development of severe angina (36% vs 42=/o). 
We conclude that PTCA of occluded vein grafts is successful in only 71% of 
cases, event rates am high in the subsequent 30 days, and when successful, 
adveme events dudng the following 3 year~ am no less frequent han in pts 
in whom PTCA was unsuccessful. Randomized trials comparing PTCA to 
repeat CABG and medical therapy in such pts am needed. 
4:45 
~ Clinical Outcome of  "High-Risk" vs  "Elective" 
Patients Undergoing Percutaneous Coronary 
Intervention: Results f rom IMPACTdl 
James J. Fergusen, Timothy J. McDonough, Seth J. Wodey, William 
J. French, John C. CorbeUi, James C, Blankenship, Daniel Carey, Frank 
V. Aguirre, Robert A, Harrington, J David Talley, A. Michael Lincetf, William 
C. Sheldon, Bonnie H. Weiner, Jan R. Resar, James E. Tcheng, Eric 
J. Topoi, Robert M. Califf on behalf of the IMPACT-II Investigators, Texas 
Heart Institute, Houston, TX 
IMPACT-II was a randomized, plecabo-controfled trial of two doses of the 
GP lib/ilia blocker, lntegmlin, in 4010 patients undergoing PTCA, with pa- 
tients stratified at enrollment to either a"high-risk" (unstable angina with EKG 
changes or acute MI) or"elective" ann. Paradoxically, Integmlin appeared to 
reduce adverse outcome events (30~ay combined rate of death, MI, or ur- 
gent revascutatizaticn) inelective but not high-risk patients. Moreover, event 
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rates in placebe-treated patients were similar in the elective and high-risk 
groups. A muitivadabfe r gression moclel showed that low weight, unstable 
angina, prior CABG, and low heart rate before drug infusion were the only 
variables significantly associated with a higher rate of 30-clay composite 
endpoints. 
Conclusions: In IMPACT-II Integrelin appeared to be effective in reducing 
event rates in elective but not high-risk patients. Thirty day event rates were 
similar for "high-risk" and "elective" patients; traditional models did no~ predict 
risk, while weight, unstable angina, prior CABG and low head rate dL:d. 
5:00 
~ Coronary Angioplasty at of the Time Initial 
Oiagnostic Cathaterization Increases the Risk of 
Major Complications 
Stephen E. Kimmel, Brian L. Strom, Warren K. Laskey and the Registry 
Committee, Society for Cardiac Angiugrapby and Interventions (SCA&I). 
University of Pennsylvania, Philadelphia, PA; University of Maryland, 
Baltimore, MD 
The safety of performing PTCA at the time of initial diagnostic athetodzation 
("ad hoc" PTCA) has not, to our knowledge, been evaluated in a bread- 
based study with sufficient statistical power. We used prospectively collected, 
detailed ata from the 1992 and 1993 SCA&I Registry databases to determine 
the dsk of ad hoc PTCA in 18,568 first, elective PTCAs done in 48 centers 
using univarlate and multivariate analyses. Procedures done emergently or 
in the setting of shock or a recent MI (within 24 hours prior to PTCA) were 
excluded. 
The dsk of major complications (MCOMP) was significantly increased in 
patients undergoing an ad hoc PTCA compared with those undergoing a 
staged procedure (Table). 
Complications Ad hoc (n = 2,711) Staged (n = 15,857) p value 
Emergency CABG 1.8% 1.2% O.Oce 
Acute MI 0.9=/o 0.5% 0.007 
Death 0.3% 0.2=/0 0.11 
MCOMP (1 or more of above) 2.(P/o 1.7% <.001 
The increased risk of ad hoc procedures was consistent among several 
subgroups of patients (e.g., presence or absence of unstable angina, multi- 
vessel disease, or head failure) and persisted even after adjusting for clinical 
and angiographic differences between ad hoc and staged procedures (mut- 
tivariable odds ratio [OR] for MCOMP 1.5; p = 0.04). The risk also was 
increased in low risk patients (no unstable angina, no MI within 2 weeks, and 
no heart failure) in whom the decision to perform an ad hoD procedure was 
unlikely to be due to the selection of stcker patients (OR for MCOMP 1.8; p 
< 0.01). 
Conclusion: In contrast to results from smaller, single institution studies, this 
large, broad-L)ased study suggests that elective, ad hoc PTCA is associated 
with an increased dsk of major complications when performed in patients 
who have not had pdor angioplasty. 
5:15 
~The Paradox Cigarette Smoking Long-Term o| and 
Benefit Alter Coronary Interventions With Platelat 
lib/Ilia Receptor Blockade 
David W.M. Muller, Koon-Hou Mak, Jeff Leimberger, Robed M. Califf, Eric 
J. Topoi. University of Michigan, Ann Arbor, MI 
Previous studies have suggested that cigarette smokers (CS) and non- 
smokers (NS) may have different coronary stanosls composition and re- 
sponse to medical therapies. To compare the clinical outcomes of PTCA for 
unstable angina in CS and NS, and their response to glycoprotein tib/llla 
Current smokers Ex-smokers Non-smokers p 
(n - 696) (n = 708) (n = 653) 
6 Month fo#ow.up (%] 
Death 2.2 2.8 3.5 ne 
Myocardial infarction 7.6 9.2 8.3 ns 
Any revascularization 22 26 29 0.02 
TL revarcularizatton 18 23 25 0.004 
Death/MI/revasc'n 27 33 34 0.005 
Outcomes by treatment: placebo/TE3 (%) 
Death 2/2 3/2 3/5 
Myocardial infarction 11/4" 9/8 11/8 
TL revascularization 22/11"* 23/20 26/25 
DeatlvMI/revasc'n 32/19" 33/29 37/32 
TL = target lesion; revasc'n = revasculadzation; "p= 0.01; **p = 0.003 
(7E3) antagonist therapy, a database of 2099 pts enrolled in a randomized 
trial was examined. CS pts were younger than NS, had fewer risk factGrs for 
coronary disease, had less extensive coronary disease, but had more severe 
symptoms; lesion morphology was similar in the 2 groups. No difference in 
procedural outcomes was apparent between CS and NS Dis. 
We conclude that i) CS have fewer complications after PTCA for unstable 
angina than NS, it) the apparent reduction in adverse events in lOtS treated 
with 7E3 is far greater in CS, iii) thrombus formation may play an important 
role in restenosis, padiculady in CS. 
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4:00 
~ Electrocardiogrsphlc Predictors of Myocardial 
Infarction in Patients Presenting With Unstable 
Angina 
Donald M. Moyd-Jones, Carlos A. Camargo Jr., Robert P. Giugliano, 
Christopher J. O'Dannell. Harva,'z/Medica/School, Boston,/HA 
Early differentiation of patients (pts) with non-ST elevation myocardial in- 
farction (MI) from those without MI has important prognostic and therapeutic 
implications. We investigated the importance of ECG and clinical parameters 
in patients presenting with unstable angina (UA) as defined by the AHCPR 
Cfinical Practice Guideline. We screened all pts admitted to intensive care 
or telemetry units via the emergency depadment from 10/91 through 9/92 to 
identify 413 consecutive pts with UA or non-ST elevation MI. After excluding 
those with predpitants (e.g. sepsis), there were 280 pts: 213 UA and 67 
ML ResultS: ST segment depressions (STD) on the initi~ ECG were signif- 
icantly associated with MI (OR 3.0, 95% C.L 1.6-5.4). Compared to those 
without STD, the presence of STD in 2 leads was no associated with MI 
(OR 1.0, 0.2-4.7), whereas STD in >_ 3 leads was (OR 3.6, 1.9--6.7). Simi- 
lady, maximal STD of 0.1 mV was not associated with M~ (OR 1.3, 0.5-3.5), 
while maximal STD of >_ 0.2 mV was (OR 4.6, 2.3-9.2). ECG fmo'ings of 
left or fight bundle branch block, left ventficular hypertJ'ophy, isolated T wave 
inversions and non-specific ST-T wave abnormalities were no signircan~ 
associated with MI. In a multivariate analysis, lOtS more likely to present 
with MI versus UA were those with STD (OR 2.9, 1.5-5.5), and particu- 
lady those with STD in >_ 3 leads (OR 3.4, 1.7-6.6) or maximal STD _ 0.2 
mV (OR 5.4, 2.5-11.6). Other multivariate predictors of MI were male gen- 
der, no history of revasculadzation, and lack of pre-admiesien beta-blocker 
therapy. 
Condus/ons: The number of involved leads and magnitude of STD provide 
important diagnostic information i  patients with acute coronary syndromes. 
Thresholds of > 3 involved leads and >_ 0.2 mV of STD defined pts at greatest 
risk for MI in this population. 
4:15 
~ Noninvasive Is Bone in Low Risk Testing Only 
Patients W'dh Unstable Angina and Non-Q-Wave 
Myocardial Infarction (Nil): Results From GUSTO-lia 
Christopher B. Granger, Robert M. Catiff, Paul W. Armstrong, Gall Harley, 
Daniel e. Mark, Eric J. Topoi for the GUSTO-Ila Investigators. Duke 
University, Durham, NC 
To investigate the current use of noninvesive testing, we studied the 1040 
patients with unstable angina/non-Q.wave MI in the GUSTO~Ila trial. Patients 
were inducted from over 200 hospitals in 12 countries from September 1993 
to April 1994. 24% of patients underwent noninvasive testing, 63% cath, 12% 
both (64% of the time stress test alter cath), and 25% neither. Noninvesive 
testing occurred a median of 6 days post enrollment. Patients undergoing 
noninvasive testing were younger (64 vs 68 yrs), less often had prior MI 
(27% vs 35%) or prior angioplesty (7 vs 13%), and were otherwise similar at 
baseline including MI at enm,ment (35 vs 3OJYo). Diagnostic medalifies were 
EGG alone 58%, thallium 24%, sestimibi 12%, and echo 6%. 
Test result: Positive Equivocal Negative No test done 
n 88 38 121 791 
Cath (alter test) 45% 9% 13% 68% 
{m) MI 5.7% 5.3% 0 6.6% 
Death 0 0 0 5.7% 
The only prognostic survival information from noninvasive testing was 
whether or not it was performed: no patient (95% CI 0-1.2%) who had 
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